Signal Transduction Pathways of the Epidermal Growth Factor Receptor in Colorectal Cancer and their Inhibition by Small Molecules

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|19|33|5735-5744

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.19, Iss.33, 2012-11, pp. : 5735-5744

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the Epidermal Growth Factor Receptor in the Treatment of Colorectal Cancer: State of the Art

By Diasio Robert B.   Fourie Jeanne  

Drugs, Vol. 66, Iss. 11, 2006-01 ,pp. : 1441-1463

Adis International

Access to resources Recommend Favorite

Targeting the Epidermal Growth Factor Receptor Family in Radionuclide Therapy of Tumors-Signal Transduction and DNA Repair

By  

Letters in Drug Design & Discovery, Vol. 3, Iss. 6, 2006-08 ,pp. : 357-368

Bentham Science Publishers

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor Inhibitors in Non-Small Cell Lung Cancer

By Dancey Janet E.  

Drugs, Vol. 67, Iss. 8, 2007-01 ,pp. : 1125-1138

Adis International

Access to resources Recommend Favorite

The Role of Downstream Signaling Pathways of the Epidermal Growth Factor Receptor for Artesunate's Activity in Cancer Cells

By  

Current Cancer Drug Targets, Vol. 9, Iss. 1, 2009-02 ,pp. : 72-80

Bentham Science Publishers

Access to resources Recommend Favorite

Gefitinib is an effective treatment for patients with non-small-cell lung cancer (NSCLC) and mutations in the epidermal growth factor receptor

By  

Inpharma, Vol. 1, Iss. 1547, 2006-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite